Seoulin Bioscience Co.,Ltd. (KOSDAQ:038070)
South Korea
· Delayed Price · Currency is KRW 6,850.00
+60.00 (0.88%)
At close: Dec 5, 2025
Seoulin Bioscience Balance Sheet
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Cash & Equivalents | 8,697 | 8,949 | 14,602 | 8,999 | 14,973 | 8,498 | Upgrade
|
| Short-Term Investments | 22,255 | 14,467 | 20,722 | 41,319 | 40,360 | 11,362 | Upgrade
|
| Trading Asset Securities | - | 93.22 | 90.3 | 4,962 | 19,999 | - | Upgrade
|
| Cash & Short-Term Investments | 30,953 | 23,510 | 35,414 | 55,280 | 75,332 | 19,860 | Upgrade
|
| Cash Growth | 24.76% | -33.62% | -35.94% | -26.62% | 279.32% | -9.89% | Upgrade
|
| Accounts Receivable | 5,742 | 7,323 | 12,986 | 6,652 | 10,137 | 8,840 | Upgrade
|
| Other Receivables | 296.29 | 528.24 | 1,291 | 630.36 | 196.33 | 68.33 | Upgrade
|
| Receivables | 6,038 | 7,851 | 14,294 | 7,282 | 10,333 | 8,908 | Upgrade
|
| Inventory | 23,000 | 26,245 | 21,785 | 17,307 | 13,933 | 11,748 | Upgrade
|
| Prepaid Expenses | 62.23 | 13.63 | 53.74 | 51.32 | 32.59 | 20.85 | Upgrade
|
| Other Current Assets | 5,217 | 2,222 | 1,408 | 7,366 | 5,352 | 924.78 | Upgrade
|
| Total Current Assets | 65,270 | 59,841 | 72,955 | 87,287 | 104,983 | 41,462 | Upgrade
|
| Property, Plant & Equipment | 16,638 | 16,628 | 18,914 | 16,491 | 14,937 | 14,541 | Upgrade
|
| Long-Term Investments | 26,072 | 19,460 | 17,512 | 25,555 | 7,515 | 6,303 | Upgrade
|
| Goodwill | 373.89 | 373.89 | 526.49 | 526.49 | 526.49 | 526.49 | Upgrade
|
| Other Intangible Assets | 370.72 | 395.06 | 425.08 | 266.64 | 230.54 | 319.14 | Upgrade
|
| Long-Term Deferred Tax Assets | 2,244 | 2,222 | 2,259 | 1,269 | 2,766 | 2,655 | Upgrade
|
| Long-Term Deferred Charges | 79.19 | 107.82 | 156.08 | 210.96 | 558.01 | 1,715 | Upgrade
|
| Other Long-Term Assets | 2,473 | 2,496 | 1,335 | 3,840 | 5,051 | 10,725 | Upgrade
|
| Total Assets | 113,520 | 101,525 | 114,100 | 135,486 | 136,566 | 78,247 | Upgrade
|
| Accounts Payable | 4,998 | 5,009 | 11,428 | 8,603 | 10,888 | 6,450 | Upgrade
|
| Accrued Expenses | 471.6 | 390.22 | 387.97 | 373.05 | 329.11 | 278.89 | Upgrade
|
| Short-Term Debt | 9,128 | 3,450 | 6,120 | 17,469 | 15,259 | 142.7 | Upgrade
|
| Current Portion of Long-Term Debt | - | - | - | 62.5 | 256.25 | 229.9 | Upgrade
|
| Current Portion of Leases | 104.36 | 156.68 | 271.44 | 69.22 | 34.65 | 3.07 | Upgrade
|
| Current Income Taxes Payable | 120.14 | - | 700.11 | 730.13 | 4,561 | 749.54 | Upgrade
|
| Other Current Liabilities | 10,540 | 4,628 | 9,122 | 19,058 | 28,112 | 5,679 | Upgrade
|
| Total Current Liabilities | 25,362 | 13,634 | 28,030 | 46,365 | 59,440 | 13,533 | Upgrade
|
| Long-Term Debt | - | - | 98.6 | 98.47 | 154.85 | 368.75 | Upgrade
|
| Long-Term Leases | 75.37 | 73.29 | 224.29 | 86.11 | 32.85 | 9.92 | Upgrade
|
| Pension & Post-Retirement Benefits | 1,227 | 478.96 | 254.11 | - | 285.87 | 1,171 | Upgrade
|
| Other Long-Term Liabilities | 492.11 | 465.66 | 253.48 | 151.59 | 150 | 1,781 | Upgrade
|
| Total Liabilities | 27,157 | 14,652 | 28,861 | 46,701 | 60,064 | 16,864 | Upgrade
|
| Common Stock | 4,550 | 4,450 | 4,350 | 4,250 | 4,150 | 4,000 | Upgrade
|
| Additional Paid-In Capital | 18,519 | 18,519 | 18,519 | 18,519 | 18,490 | 18,490 | Upgrade
|
| Retained Earnings | 69,230 | 69,170 | 67,177 | 68,475 | 58,805 | 44,024 | Upgrade
|
| Treasury Stock | -4,555 | -4,496 | -3,404 | -3,261 | -3,062 | -2,981 | Upgrade
|
| Comprehensive Income & Other | -3,270 | -3,751 | -3,581 | -3,581 | -3,523 | -3,613 | Upgrade
|
| Total Common Equity | 84,474 | 83,893 | 83,063 | 84,403 | 74,861 | 59,920 | Upgrade
|
| Minority Interest | 1,889 | 2,980 | 2,177 | 4,382 | 1,642 | 1,463 | Upgrade
|
| Shareholders' Equity | 86,364 | 86,872 | 85,239 | 88,785 | 76,502 | 61,383 | Upgrade
|
| Total Liabilities & Equity | 113,520 | 101,525 | 114,100 | 135,486 | 136,566 | 78,247 | Upgrade
|
| Total Debt | 9,307 | 3,680 | 6,714 | 17,785 | 15,738 | 754.35 | Upgrade
|
| Net Cash (Debt) | 21,645 | 19,830 | 28,700 | 37,495 | 59,594 | 19,105 | Upgrade
|
| Net Cash Growth | -6.09% | -30.91% | -23.46% | -37.08% | 211.92% | -12.29% | Upgrade
|
| Net Cash Per Share | 2309.12 | 2274.97 | 3276.17 | 3447.13 | 6778.62 | 2171.72 | Upgrade
|
| Filing Date Shares Outstanding | 8.62 | 8.76 | 8.56 | 8.57 | 8.57 | 8.47 | Upgrade
|
| Total Common Shares Outstanding | 8.62 | 8.76 | 8.76 | 8.78 | 8.79 | 8.8 | Upgrade
|
| Working Capital | 39,908 | 46,207 | 44,924 | 40,922 | 45,543 | 27,928 | Upgrade
|
| Book Value Per Share | 9802.92 | 9580.47 | 9477.06 | 9616.87 | 8517.25 | 6811.65 | Upgrade
|
| Tangible Book Value | 83,730 | 83,124 | 82,111 | 83,610 | 74,104 | 59,074 | Upgrade
|
| Tangible Book Value Per Share | 9716.51 | 9492.66 | 9368.49 | 9526.50 | 8431.12 | 6715.52 | Upgrade
|
| Land | 4,074 | 3,967 | 4,246 | 3,721 | 3,185 | 3,118 | Upgrade
|
| Buildings | 11,295 | 11,263 | 12,539 | 11,192 | 10,642 | 10,563 | Upgrade
|
| Machinery | 956.13 | 1,026 | 1,474 | 1,193 | 851.95 | 631.66 | Upgrade
|
| Construction In Progress | - | - | - | 6 | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.